BJOG : an international journal of obstetrics and gynaecology · 2000
Which women should be tested for Chlamydia trachomatis?
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Macmillan S, McKenzie H, Flett G, Templeton A
Аннотация
OBJECTIVE: To assess the prevalence of genitourinary Chlamydia trachomatis infection among women in different clinical settings, with a view to making decisions about who should be tested routinely.
DESIGN: Cross sectional study.
SETTING: One regional hospital and family planning clinic serving an urban centre. Population Two thousand thirty-five sexually active women attending various outpatient settings.
MAIN OUTCOME MEASURES: Prevalence of positivity by clinical setting, stratified by age.
RESULTS: Overall, prevalence of lower genital tract chlamydial infection was similar in a variety of clinical settings. Infertile women were the only exception, demonstrating a much lower prevalence. Stratifying the study population by age found a clear trend towards high prevalence in teenagers and virtually no infection in women over the age of 30 years.
CONCLUSIONS: The prevalence of chlamydial infection in women is related to age, regardless of clinical presentation. In practice, opportunistic screening should target sexually active women under 30 years of age.
DESIGN: Cross sectional study.
SETTING: One regional hospital and family planning clinic serving an urban centre. Population Two thousand thirty-five sexually active women attending various outpatient settings.
MAIN OUTCOME MEASURES: Prevalence of positivity by clinical setting, stratified by age.
RESULTS: Overall, prevalence of lower genital tract chlamydial infection was similar in a variety of clinical settings. Infertile women were the only exception, demonstrating a much lower prevalence. Stratifying the study population by age found a clear trend towards high prevalence in teenagers and virtually no infection in women over the age of 30 years.
CONCLUSIONS: The prevalence of chlamydial infection in women is related to age, regardless of clinical presentation. In practice, opportunistic screening should target sexually active women under 30 years of age.